- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04436666
Virtual Reality, Ice Application and Self-injection and Self-test Fair, Pain and State Anxiety
The Effect of Virtual Reality and Ice Application on Fear of Self-injection and Self-test, Pain and State Anxiety Levels in Patients With Type 2 Diabetes
AİM:The aim of this study is to control the fears and anxieties of Type 2 diabetics in insulin injection and blood glucose measurement with motivational videos and Ice applications to be applied with virtual reality glasses.
Material and Methods: The research is designed as a semi-experimental model with pretest-posttest control groups. The research will be carried out in the endocrine services located in Turgut Özal Medical Center in Malatya province. The universe of the research will be 2113 Type 2 diabetes patients who are being treated in the hospital specified on the specified dates, who are injecting insulin and following blood sugar. According to the analysis of the power, the sample of the research is composed of an experiment effect of 0.5% with bilateral significance level, 95% confidence interval determined with 5% error level, the experiment group to be applied with 80% Reality with 80% representation power, and the control group with 80 ice application. will create a total of 240 Type 2 diabetes patients.In the collection of the data, the Participant Presentation Form developed by the researcher, Diabetes Fear of Self Injecting and Self-testing Questionnaire-D-FISQ, State Anxiety Scale and VAS will be used.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
VR is a relatively new human-computer interaction tool in which a person becomes an active participant in a virtual world. Sensory cues of VR, especially the precise control of auditory, tactile and olfactory systems, enhances the reality of the virtual environment. As a result, users feel that they can look around and enter the simulated environment. The virtual environment provides sensory information such as visual, auditory, movement, virtual or artificial, and makes the individual feel similar to real life.
Ice application has been used as a topical pain reliever for centuries. It works through a variety of mechanisms, such as slowing the transmission of peripheral nerve fibers, promoting sensory competition, and reducing the release of inflammatory and nociceptive mediators. Ice application is cheap, easily accessible and reaches its purpose relatively quickly to skin anesthesia. Apart from these effects, it also reduces pain by activating the Door-Control mechanism, stimulating the touch receptors and increasing the release of endogenous opioids.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Malatya, Turkey, 44280
- seher ÇEVİK
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Being literate,
- Injecting insulin at least twice a day,
- Following blood sugar at least twice a day,
Exclusion Criteria:
Having any psychiatric diagnosis,
- communication barriers
- The patient has any diagnosis, such as epilepsy, that will trigger seizures.
- Any diagnosis, such as vertigo, that causes dizziness in the patient.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ice Application
Music-funded, park, nature and seaside walks, submarine, museum, with virtual reality glasses (Bobo VR Z4 Binocular Glasses and 5.7 inch 1440x2560 pixel display resolution, China) for 10 minutes to diabetic patients before blood glucose measurement and insulin injection The videos that the patient wants to watch will be watched from videos such as his trip Studies have indicated that these videos are relaxing environments, and motion videos should not be watched to reduce nausea and vomiting.
|
Before the blood glucose measurement and insulin injection, patients with diabetes will be given ice for 5 minutes.
It is planned to apply ice cubes in liquid-proof ice bags.
|
Experimental: Virtual Reality
Before the blood glucose measurement and insulin injection, patients with diabetes will be given ice for 5 minutes.
It is planned to apply ice cubes in liquid-proof ice bags.
|
Music-funded, park, nature and seaside walks, submarine, museum, with virtual reality glasses (Bobo VR Z4 Binocular Glasses and 5.7 inch 1440x2560 pixel display resolution, China) for 10 minutes to diabetic patients before blood glucose measurement and insulin injection The videos that the patient wants to watch will be watched from videos such as his trip Studies have indicated that these videos are relaxing environments, and motion videos should not be watched to reduce nausea and vomiting.
|
No Intervention: control
No Intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Injection fear reduction
Time Frame: 1 month
|
(Diabetes Fear of Self Injecting and Self-testing Questionnaire-D-FISQ) D-FISQ was developed by Snoek et al. (1997) to measure the fear of self-injection and testing in individuals with diabetes who need insulin.
D-FISQ with 15 expressions consists of two sub-dimensions, fear of self-injecting-FSI, 6 expressions, and fear of self-testing (FST, 9 expressions).
Each statement has a 4-point Likert-type rating ranging from 1 to 4 (1 = almost never, 2 = sometimes, 3 = often, 4 = almost always).
The evaluation of the inquiry form can be done by taking the average or raw score for the two sub-dimensions and the whole form.
As the scores obtained from the scale increase, fear levels increase.
Internal consistency coefficient of the scale is 0.96.
|
1 month
|
anxiety reducation
Time Frame: 1 month
|
State Anxiety Scale The scale, which was developed by Spielberger et al in 1970, was adapted to Turkish by Öner and LeCompte (1974).
The emotions or behaviors expressed in the scale items are answered by marking one of the options such as (1) none, (2) a little, (3) a lot, and (4) completely.
The scale containing twenty expressions contains 10 inverse (1, 2, 5, 8, 10, 11, 15, 16, 19, 20) expressions.
While the reverse expressions expressing positive emotions are scored, those in one weight degree are converted into four, and those in four weight degrees into one.
In the scoring, the total weighted score of the inverse statements is subtracted from the total weighted score and 50, an unchanged value, is added to this number.
The total score value obtained from the scale can range from 20 to 80 points.
A high score indicates that the level of anxiety is high.
The total score value is evaluated as 20-39 mild anxiety, 40-59 moderate anxiety, and 60-79 severe anxiety.
|
1 month
|
pain relief
Time Frame: 1 month
|
(Visual Analogue Scale -VAS) This scale, which is used to measure subjectively perceived pain, was developed by Price et al. (1983), and has been used in many studies to evaluate the intensity of pain, it has been found to be reliable and valid.
It is a 10 cm scale with "painlessness" on one end and "severe pain" on the other.
Individuals participating in the study are asked to mark the level of pain severity they feel at the moment, explaining that the number "0" on the scale means that I do not feel any pain and the pain intensity increases as the numbers grow and the number "10" means the most severe pain.
|
1 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: seher ÇEVİK, Inonu University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- seher cevik
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Injection Site Irritation
-
Ankara Diskapi Training and Research HospitalCompleted
-
Wake Forest University Health SciencesTerminatedPain | Injection Site IrritationUnited States
-
Ankara City Hospital BilkentCompletedInjection Site IrritationTurkey
-
King Khalid University HospitalCompleted
-
Suleyman Demirel UniversityCompletedInjection Site Irritation
-
Emory UniversityRecruitingInjection Site IrritationUnited States
-
Tanta UniversityCompletedInjection Site IrritationSaudi Arabia
-
Jeffrey Alan Klein, MDNot yet recruitingAnesthesia, Local | Injection Site Irritation | Injection Site Discomfort | Injection Site Bruising | Benzoic Acid Adverse ReactionUnited States
-
University of MinnesotaRecruitingInjection Site Irritation | Anesthesia; HypothermiaUnited States
-
Eitan MedicalThomas Jefferson UniversityRecruitingInjection Site Irritation | Injection Site Reaction | Injection SiteUnited States
Clinical Trials on Ice Application
-
Istanbul Medipol University HospitalCompleted
-
University of Health Sciences LahoreNot yet recruiting
-
Sülayman YAMANCompletedHemodialysis AccessTurkey
-
Michigan State UniversityCompletedFocus of Study is to Determine Efficacy of CompexUnited States
-
Asmaa Abdallah Ahmed HusseinCairo UniversityCompleted
-
Izmir Katip Celebi UniversityCompleted
-
University of MinnesotaRecruitingInjection Site Irritation | Anesthesia; HypothermiaUnited States
-
Akdeniz UniversityCompletedPain, Acute | Thoracic Injury | Post Operative PainTurkey
-
LI-JU ChenCompletedHeart Failure | Thirst | SalivaTaiwan
-
Philips Clinical & Medical Affairs GlobalActive, not recruitingStroke | Atrial Fibrillation | Aortic Valve Disease | Atrial Septal Defect | Patent Foramen Ovale | Valve Disease, Heart | Mitral Valve Disease | Tricuspid Valve DiseaseUnited States